Results 111 to 120 of about 237,979 (279)
Grand challenges and living labs: toward achieving the Sustainable Development Goals. [PDF]
Molnar A, Lepenies R, Borda A, Pedell S.
europepmc +1 more source
As societies scramble for ways to surmount current sustainability challenges, living labs have emerged as hopeful hybrid institutions to facilitate collaboration.
Julia Backhaus, Stefan John
doaj +1 more source
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Innovation through the Quintuple Helix in living labs: lessons learned for a transformation from lab to ecosystem. [PDF]
Merino-Barbancho B +8 more
europepmc +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Living labs for civic technologies: a case study. Community infrastructuring for a volunteer firefighting service. [PDF]
Viano C +8 more
europepmc +1 more source
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Urban living labs as innovation infrastructure for local urban intervention acceleration and student social learning: the impacts on community wellbeing in Heerlen. [PDF]
Blezer S, Abujidi N, Sap H.
europepmc +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Urban Living Labs: how to enable inclusive transdisciplinary research? [PDF]
Laborgne P +10 more
europepmc +1 more source

